InvestorsHub Logo
Followers 32
Posts 2552
Boards Moderated 0
Alias Born 07/16/2006

Re: alertmeipp post# 34189

Tuesday, 08/17/2010 10:59:43 PM

Tuesday, August 17, 2010 10:59:43 PM

Post# of 50143
As we all are. The positive aspect to the option approach is that is helps small companies get to the data inflection point--where the larger Pharma is willing to commit. The BP pays some now, in return for paying less in total if they exercise the option. I'd rather see Cortex not have to dilute at a poor price in order to get to Phase IIa data.

NeuroInvestment
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News